E-LIB Suche - Ergebnisse für: Lingzhi Hong, MD

1

Predicting benefit from immune checkpoint inhibitors in pat..:

Maliazurina B Saad, PhD ; Lingzhi Hong, MD ; Muhammad Aminu, MD...
http://www.sciencedirect.com/science/article/pii/S2589750023000821. , 2023

Link: https://doi.org/10.1016/..

2

Brief Report: Clinical Response, Toxicity, and Resistance M..:

Kaiwen Wang, PharmD ; Robyn Du, BS ; Sinchita Roy-Chowdhuri, MD...
http://www.sciencedirect.com/science/article/pii/S2666364323000723. , 2023

Link: https://doi.org/10.1016/..

3

Efficacy of Targeted Inhibitors in Metastatic Lung Squamous..:

Whitney E. Lewis, PharmD ; Lingzhi Hong, MD, PhD ; Frank E. Mott, MD...
http://www.sciencedirect.com/science/article/pii/S2666364321000965. , 2021

Link: https://doi.org/10.1016/..

4

Enhancing NSCLC recurrence prediction with PET/CT habitat i..:

Sujit, Sheeba J. ; Aminu, Muhammad ; Karpinets, Tatiana V....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

5

Synthetic PET from CT improves diagnosis and prognosis for ..:

Salehjahromi, Morteza ; Karpinets, Tatiana V. ; Sujit, Sheeba J....
Cell Reports Medicine. 5 (2024) 3 - p. 101463 , 2024

Link: https://doi.org/10.1016/..

6

Real-World Efficacy and Safety of Amivantamab for EGFR-Muta..:

Wang, Kaiwen ; Du, Robyn ; Myall, Nathaniel J....
Journal of Thoracic Oncology. 19 (2024) 3 - p. 500-506 , 2024

Link: https://doi.org/10.1016/..

7

Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Asso..:

Qin, Kang ; Wang, Kaiwen ; Li, Shenduo...
Cancers. 16 (2024) 5 - p. 935 , 2024

Link: https://doi.org/10.3390/..

8

Integrative genomic and transcriptomic profiling of pulmona..:

Seth, Sahil ; Chen, Runzhe ; Liu, Yang...
Cancer Innovation. 3 (2024) 3 - p. , 2024

Link: https://doi.org/10.1002/..

9

ATM Mutations Associate with Distinct Co-Mutational Pattern..:

Vokes, Natalie I. ; Galan Cobo, Ana ; Fernandez-Chas, Margarita...
Clinical Cancer Research. 29 (2023) 23 - p. 4958-4972 , 2023

Link: https://doi.org/10.1158/..

10

Brief Report: Clinical Response, Toxicity, and Resistance M..:

Wang, Kaiwen ; Du, Robyn ; Roy-Chowdhuri, Sinchita...
JTO Clinical and Research Reports. 4 (2023) 8 - p. 100533 , 2023

Link: https://doi.org/10.1016/..

11

Pathomic Features Reveal Immune and Molecular Evolution Fro..:

Chen, Pingjun ; Rojas, Frank R. ; Hu, Xin...
Modern Pathology. 36 (2023) 12 - p. 100326 , 2023

Link: https://doi.org/10.1016/..

12

Predicting benefit from immune checkpoint inhibitors in pat..:

Saad, Maliazurina B ; Hong, Lingzhi ; Aminu, Muhammad...
The Lancet Digital Health. 5 (2023) 7 - p. e404-e420 , 2023

Link: https://doi.org/10.1016/..

13

Efficacy and clinicogenomic correlates of response to immun..:

Hong, Lingzhi ; Aminu, Muhammad ; Li, Shenduo...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

14

MET Amplification as a Resistance Driver to TKI Therapies i..:

Qin, Kang ; Hong, Lingzhi ; Zhang, Jianjun.
Cancers. 15 (2023) 3 - p. 612 , 2023

Link: https://doi.org/10.3390/..

15

Automated Cellular-Level Dual Global Fusion of Whole-Slide ..:

Diao, Songhui ; Chen, Pingjun ; Showkatian, Eman...
Cancers. 15 (2023) 19 - p. 4824 , 2023

Link: https://doi.org/10.3390/..